Consolidated Statements of Operations and Other Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Revenue
Total Revenue	$ 4,480,442	$ 19,798,822
Operating Expenses
Cost of Sales	3,731,990	11,301,814
General and Administrative	7,837,826	23,491,130
Total Operating Expenses	11,569,816	34,792,944
Operating Losses from Operations	(7,089,374)	(14,994,122)
Other Income (Expense)
Interest Income	67,470	183,636
Interest Expense	(1,853)	(317,281)
Foreign Exchange Transaction (Loss) Gain	(547,845)	1,363,061
Unrealized Loss on Securities Investment	(7,794,139)	(1,959,664)
Unrealized Loss on Securities Investment - Related Party	(23,556,219)	(47,231,084)
Realized Loss on Securities Investment	(7,308,580)	(4,698,078)
Loss on Investment on Security by Equity Method	(685,533)	(51,999)
Finance Costs	(450,000)	(50,871,869)
Other Income	1,153,568	93,823
Total Other Expense, Net	(39,123,131)	(103,489,455)
Net Loss Income Before Income Taxes	(46,212,505)	(118,483,577)
Income Tax Expense		(534,014)
Net Loss	(46,212,505)	(119,017,591)
Net Loss Attributable to Non-Controlling Interest	(5,721,567)	(15,694,415)
Net Loss Attributable to Common Stockholders	(40,490,938)	(103,323,176)
Other Comprehensive Loss, Net
Unrealized Gain (Loss) on Securities Investment	40,201	(57,179)
Foreign Currency Translation Adjustment	508,277	(3,974,966)
Comprehensive Loss	(45,664,027)	(123,049,736)
Comprehensive Loss Attributable to Non-controlling Interests	(5,620,606)	(16,933,170)
Comprehensive Loss Attributable to Common Stockholders	$ (40,043,421)	$ (106,116,566)
Net Loss Per Share - Basic and Diluted	$ (6.22)	$ (73.85)
Weighted Average Common Shares Outstanding - Basic and Diluted	6,513,453	1,399,144
Rental [Member]
Revenue
Total Revenue	$ 1,810,011	$ 327,296
Property [Member]
Revenue
Total Revenue	1,278,617	13,886,083
Biohealth [Member]
Revenue
Total Revenue	753,651	5,543,066
Digital Transformation Technology [Member]
Revenue
Total Revenue	69,915
Other [Member]
Revenue
Total Revenue	$ 568,248	$ 42,377